Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile

Orbis Medicines

Investment area
Seed Investments
Region
Europe
Date of investment
September 2021

Novel macrocyclic chemistry and computational platform for high-throughput drug discovery

Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile

Orbis Medicines

Investment area
Seed Investments
Region
Europe
Date of investment
September 2021

Novel macrocyclic chemistry and computational platform for high-throughput drug discovery

Orbis Medicines

Investment area
Seed Investments
Region
Europe
Date of investment
September 2021

Novel macrocyclic chemistry and computational platform for high-throughput drug discovery

Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile